131 related articles for article (PubMed ID: 27681934)
21. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
[TBL] [Abstract][Full Text] [Related]
22. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
23. Increased plasma level of catestatin might be associated with poor prognosis in hemodialysis patients.
Sun H; Xian W; Geng L; Li E; Peng Z; Tian J
Int Urol Nephrol; 2017 Jun; 49(6):1063-1069. PubMed ID: 28161844
[TBL] [Abstract][Full Text] [Related]
24. Prognostic differences of catestatin among young and elderly patients with acute myocardial infarction.
Xu WX; Fan YY; Song Y; Liu X; Liu H; Guo LJ
World J Emerg Med; 2022; 13(3):169-174. PubMed ID: 35646208
[TBL] [Abstract][Full Text] [Related]
25. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
27. ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes.
Zha Y; Chen Y; Xu F; Li T; Zhao C; Cui L
Biomed Pharmacother; 2010 Mar; 64(3):160-4. PubMed ID: 19944557
[TBL] [Abstract][Full Text] [Related]
28. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
[TBL] [Abstract][Full Text] [Related]
29. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
[TBL] [Abstract][Full Text] [Related]
30. Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.
Meng L; Ye XJ; Ding WH; Yang Y; Di BB; Liu L; Huo Y
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):643-7. PubMed ID: 21508845
[TBL] [Abstract][Full Text] [Related]
31. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
32. Relationship between serum vasoactive factors and plaque morphology in patients with non-ST-segment elevated acute coronary syndrome.
Lu YF; Lü SZ; Chen YD
Chin Med J (Engl); 2010 Jan; 123(2):193-7. PubMed ID: 20137369
[TBL] [Abstract][Full Text] [Related]
33. Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes.
Coskun S; Atalar E; Ozturk E; Yavuz B; Ozer N; Goker H; Ovünç K; Aksöyek S; Kes S; Sivri B; Kirazli S; Ozmen F
J Natl Med Assoc; 2006 Nov; 98(11):1746-50. PubMed ID: 17128682
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention.
Mueller C; Neumann FJ; Perruchoud AP; Zeller T; Buettner HJ
Am J Med; 2004 Dec; 117(12):897-902. PubMed ID: 15629727
[TBL] [Abstract][Full Text] [Related]
35. Outcome of percutaneous coronary intervention in unstable angina pectoris versus stable angina pectoris in two different time periods.
Naidu SS; Polin GM; Selzer F; Laskey WK; Jacobs AK; Williams DO; Wilensky RL
Am J Cardiol; 2006 Aug; 98(4):447-52. PubMed ID: 16893695
[TBL] [Abstract][Full Text] [Related]
36. Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction.
Wang X; Xu S; Liang Y; Zhu D; Mi L; Wang G; Gao W
Biomarkers; 2011 Jun; 16(4):372-7. PubMed ID: 21545240
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome.
Malý M; Vojácek J; Hrabos V; Kvasnicka J; Salaj P; Durdil V
Physiol Res; 2003; 52(6):719-28. PubMed ID: 14640893
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction.
Pei Z; Ma D; Ji L; Zhang J; Su J; Xue W; Chen X; Wang W
Peptides; 2014 May; 55():131-5. PubMed ID: 24631953
[TBL] [Abstract][Full Text] [Related]
39. In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome.
Ma P; Han L; Lv Z; Chen W; Hu H; Tu J; Zhou X; Liu SM
BMC Cardiovasc Disord; 2016 Feb; 16():29. PubMed ID: 26830193
[TBL] [Abstract][Full Text] [Related]
40. miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI.
O Sullivan JF; Neylon A; McGorrian C; Blake GJ
Int J Cardiol; 2016 Dec; 224():310-316. PubMed ID: 27665403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
